Apollo Hospitals Enterprise Limited
NSE: APOLLOHOSP BSE: APOLLOHOSP
Prev Close
6784.3
Open Price
6786.25
Volume
204,519
Today Low / High
6770.35 / 6895
52 WK Low / High
5693.2 / 7545.35
Range
6,483 - 7,166
Upper Circuit (5%)
7,165.88
Lower Circuit (5%)
6,483.42
Prev Close
6778.35
Open Price
6775
Volume
3,747
Today Low / High
6775 / 6894.75
52 WK Low / High
5690.8 / 7545.1
Range
6,486 - 7,169
Upper Circuit (5%)
7,168.93
Lower Circuit (5%)
6,486.17
The stock performance of Apollo Hospitals Enterprise Limited on both the NSE and BSE. On the NSE, the stock is priced at ₹6824.65 (target range: ₹6,483 - ₹7,166), reflecting a slight increase of 0.59%, with a trading volume of 204,519 shares. On the BSE, the stock is trading at ₹6827.55 (target range: ₹6,486 - ₹7,169), up by 0.73% with a volume of 3,747 shares. Both exchanges show similar low and high prices, with NSE at ₹6770.35 - ₹6895 and BSE at ₹6775 - ₹6894.75 The 52-week range stands at ₹7545.35 - ₹5693.2 on both exchanges. Both NSE and BSE show positive movement, indicating an upward stock trend—an appealing opportunity for growth-focused investors.
Apollo Hospitals Enterprise Limited Chart Graph
Comprehensive Overview of Apollo Hospitals Enterprise Limited
ISIN
INE437A01024
Industry
Medical - Care Facilities
Vol.Avg
367,638
Market Cap
981,282,300,250
Last Dividend
16
Range
5693.2-7545.35
Official Website
IPO Date
2002-07-01
DCF Diff
2,971.71
DCF
3,851
Latest Dividend Details for APOLLOHOSP
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-08-16 | August 16, 24 | 10 | 10 | 2024-08-17 | 2024-09-09 | |
| 2024-02-20 | February 20, 24 | 6 | 6 | 2024-02-20 | 2024-03-06 | |
| 2023-08-18 | August 18, 23 | 9 | 9 | 2023-08-19 | 2023-09-27 | |
| 2023-02-24 | February 24, 23 | 6 | 6 | 2023-02-24 | 2023-03-10 | |
| 2022-08-18 | August 18, 22 | 11.75 | 11.75 | 2022-08-19 | 2022-09-06 |
Comprehensive Annual Financial Performance Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 19,059.20 Cr | 15,570.70 Cr | 3,488.50 Cr | 0.1830 | 23.40 Cr | 152.40 Cr | 1,707.30 Cr | 898.60 Cr | 62.50 | 2,402.00 Cr | 0.0471 |
| 2023-03-31 | 16,612.45 Cr | 8,574.23 Cr | 8,038.22 Cr | 0.4839 | 21.10 Cr | 1,492.90 Cr | 1,449.20 Cr | 819.10 Cr | 56.97 | 2,139.30 Cr | 0.0493 |
| 2022-03-31 | 14,536.20 Cr | 7,573.50 Cr | 6,962.70 Cr | 0.4790 | 11.00 Cr | 1,219.10 Cr | 1,588.40 Cr | 1,055.60 Cr | 73.42 | 2,556.80 Cr | 0.0726 |
| 2021-03-31 | 10,468.00 Cr | 5,684.20 Cr | 4,783.80 Cr | 0.4570 | 0.00 Cr | 718.30 Cr | 567.20 Cr | 150.40 Cr | 10.74 | 1,242.40 Cr | 0.0144 |
| 2020-03-31 | 11,171.50 Cr | 5,498.90 Cr | 5,672.60 Cr | 0.5078 | 0.00 Cr | 804.90 Cr | 971.30 Cr | 454.90 Cr | 32.69 | 1,811.90 Cr | 0.0407 |
Essential Financial Ratios Every Investor Must Know
Comprehensive Annual Balance Sheet Overview
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 505.50 Cr | 16,753.10 Cr | 9,432.60 Cr | 6,935.4000 Cr | 5,332.60 Cr | 4,827.10 Cr | 459.80 Cr | 9,385.20 Cr | 135.60 Cr | 0.00 Cr | 356.70 Cr | 4,664.5000 Cr |
| 2023-03-31 | 433.42 Cr | 14,427.73 Cr | 7,896.45 Cr | 6,197.1400 Cr | 4,332.36 Cr | 3,898.94 Cr | 390.19 Cr | 8,033.73 Cr | 275.03 Cr | 673.62 Cr | 414.50 Cr | 3,324.8000 Cr |
| 2022-03-31 | 583.00 Cr | 13,192.40 Cr | 7,314.70 Cr | 5,623.3000 Cr | 4,068.10 Cr | 3,485.10 Cr | 431.90 Cr | 7,279.20 Cr | 408.00 Cr | 622.00 Cr | 390.10 Cr | 2,383.3000 Cr |
| 2021-03-31 | 425.20 Cr | 11,416.70 Cr | 6,614.30 Cr | 4,602.5000 Cr | 4,159.70 Cr | 3,734.50 Cr | 249.50 Cr | 6,545.80 Cr | 372.10 Cr | 612.40 Cr | 344.90 Cr | 2,037.8000 Cr |
| 2020-03-31 | 380.70 Cr | 11,338.40 Cr | 7,868.60 Cr | 3,339.1000 Cr | 5,620.70 Cr | 5,240.00 Cr | 737.80 Cr | 7,260.90 Cr | 338.80 Cr | 517.40 Cr | 359.20 Cr | 2,337.3000 Cr |
Annual Financial Cash Flow Statement Overview
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 1,920.2000 Cr | -1,537.2000 Cr | -311.1000 Cr | 783.4000 Cr | 72.1000 Cr | 505.5000 Cr | -1,136.8000 Cr | 898.6000 Cr | 224.6000 Cr | -215.7000 Cr | -69.2000 Cr |
| 2023-03-31 | 1,377.0500 Cr | -870.6100 Cr | -633.3300 Cr | 248.5300 Cr | -113.1300 Cr | 433.4200 Cr | -1,128.5200 Cr | 844.5700 Cr | 68.8000 Cr | -255.2000 Cr | 41.9300 Cr |
| 2022-03-31 | 1,628.0000 Cr | -778.2000 Cr | -792.6000 Cr | 970.8000 Cr | 157.8000 Cr | 583.0000 Cr | -657.2000 Cr | 1,108.4000 Cr | -493.1000 Cr | -43.3000 Cr | -175.8000 Cr |
| 2021-03-31 | 1,273.4000 Cr | -872.3000 Cr | -340.1000 Cr | 977.9000 Cr | 44.5000 Cr | 425.2000 Cr | -295.5000 Cr | 136.8000 Cr | -898.5000 Cr | -38.3000 Cr | -94.6000 Cr |
| 2020-03-31 | 1,292.8000 Cr | -288.8000 Cr | -909.5000 Cr | 779.8000 Cr | 94.5000 Cr | 380.7000 Cr | -513.0000 Cr | 431.7000 Cr | -186.0000 Cr | -155.1000 Cr | -153.1000 Cr |
Quarterly Financial Performance Highlights
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 5,589.30 Cr | 2,857.70 Cr | 2,731.60 Cr | 0.4887 | 631.00 Cr | 378.80 Cr | 26.34 | 859.40 Cr | 0.0678 |
| 2024-06-30 | 5,085.60 Cr | 3,458.50 Cr | 1,627.10 Cr | 0.3199 | 497.70 Cr | 305.20 Cr | 21.23 | 712.30 Cr | 0.0600 |
| 2024-03-31 | 4,943.90 Cr | 3,380.30 Cr | 1,563.60 Cr | 0.3163 | 450.80 Cr | 253.80 Cr | 17.65 | 668.60 Cr | 0.0513 |
| 2023-12-31 | 4,850.60 Cr | 2,533.10 Cr | 2,317.50 Cr | 0.4778 | 475.90 Cr | 245.30 Cr | 17.06 | 641.50 Cr | 0.0506 |
| 2023-09-30 | 4,846.90 Cr | 2,458.50 Cr | 2,388.40 Cr | 0.4928 | 488.40 Cr | 232.90 Cr | 16.20 | 651.60 Cr | 0.0481 |
Comprehensive Quarterly Financial Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 1,435.30 Cr | 2,008.70 Cr | 3,444.00 Cr | 0.00 Cr | 448.20 Cr | 7,338.20 Cr | 10,084.40 Cr | 19,547.90 Cr | 11,633.30 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 1,189.50 Cr | 0.00 Cr | 0.00 Cr | 1,189.50 Cr | 0.00 Cr | 0.00 Cr | -7,320.50 Cr |
| 2024-03-31 | 933.80 Cr | 684.00 Cr | 1,617.80 Cr | 2,818.00 Cr | 459.80 Cr | 5,279.70 Cr | 9,385.20 Cr | 16,753.10 Cr | 9,432.60 Cr |
| 2023-12-31 | -1,431.40 Cr | 2,862.80 Cr | 1,431.40 Cr | 0.00 Cr | 0.00 Cr | 1,431.40 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 472.40 Cr | 1,089.40 Cr | 1,561.80 Cr | 2,549.90 Cr | 423.40 Cr | 4,887.80 Cr | 8,498.70 Cr | 15,560.90 Cr | 8,683.30 Cr |
Quarterly Cash Flow Statement: A Detailed Financial Overview
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 305.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 253.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 245.30 Cr | 334.00 Cr | 0.00 Cr | 0.00 Cr | 334.00 Cr | 1,203.00 Cr | 869.00 Cr | 0.00 Cr | 334.00 Cr |
| 2023-09-30 | 232.90 Cr | 326.80 Cr | 0.00 Cr | 0.00 Cr | 326.80 Cr | 869.00 Cr | 542.20 Cr | 0.00 Cr | 326.80 Cr |
| 2023-06-30 | 166.60 Cr | 29.20 Cr | 0.00 Cr | 0.00 Cr | -675.50 Cr | 29.20 Cr | 704.70 Cr | 0.00 Cr | 29.20 Cr |
Historical Stock Splits Overview
| Date | Label | Split Ratio |
|---|---|---|
| 2010-09-02 | September 02, 10 | 2:1 |
Executive Profiles
Gender: male
Year Born: 1952
Gender: male
Year Born: 1975
Gender: Not Specified
Year Born: 1962
Gender: female
Year Born: 1959
Gender: male
Year Born: 1955
Gender: male
Year Born: 1969
Gender: female
Year Born: 1982
Gender: Not Specified
Year Born: 1932
Gender: male
Year Born: 1969
Gender: Not Specified
Year Born: 1957
Frequently Asked Questions about Apollo Hospitals Enterprise Limited
The CEO of the company is Dr. Prathap Chandra Reddy FCCP, FICA, FRCS, M.D., MBBS.
The current trading price of the stock is ₹6,824.65.
The 52-week price range of this stock is ₹5693.2-7545.35.
The market capitalization of the company is ₹98,128.23 crores.
The dividend yield represents the percentage of a company stock price paid out as dividends annually. For example, if the dividend yield is 0.23%, it means the company pays this percentage of its stock price as a dividend each year.
The P/E ratio is a measure of a company stock price relative to its earnings per share (EPS). For this stock, the current P/E ratio is 82.96.
The company operates in the Healthcare sector.
The current price of Apollo Hospitals Enterprise Limited is ₹6,824.65. If the stock takes a bullish turn, you can expect the target price to be around ₹7,165.88. On the other hand, if the market turns bearish, the target price could drop to approximately ₹6,483.42.
The company, Apollo Hospitals Enterprise Limited (ISIN: INE437A01024), is a leading player in the Medical - Care Facilities sector in India. With a market capitalization of ₹98,128.23 crores and an average daily trading volume of 367,638 shares, it is actively engaged in the Medical - Care Facilities industry. The company recently declared a dividend of 16."